ConMed CEO to retire, successor named

NEW HARFTORD, N.Y. — ConMed Corp. (NYSE: CNMD) President/CEO Curt R. Hartman will retire effective Jan. 1, 2025, and Patrick Beyer, current COO of the medical-device company, will succeed him in the role, ConMed announced. Beyer will also be appointed to the board of directors at that time. “It has been a privilege to lead ConMed for the past decade, and I am incredibly proud of what we have accomplished together,” Hartman said in a news release. “The team has transformed this business into a world-class organization with a truly innovative portfolio driven by both internal research and development as well as several successful acquisitions. I am thrilled to be succeeded by Pat, as we’ve worked closely together for many years, and he was my first leadership hire when I joined ConMed in 2014. Since assuming the role of chief operating officer this past April, Pat has already made a positive impact on the business, and I look forward to seeing ConMed advance even further under his leadership.” Beyer joined ConMed in 2014 as president of international before being promoted to president of international and global orthopedics in October 2020. In 2022, he led the process of acquiring both In2Bones and BioRez. Once promoted to chief operating officer, Beyer took on additional responsibility for leading the company’s commercial business as well as operations, distribution, regulatory affairs/quality assurance, and customer excellence. Prior to joining ConMed, Beyer spent 21 years at Stryker in leadership roles and nearly four years as CEO of ICNet International. “I am honored to succeed Curt and am deeply appreciative of his leadership and mentorship over the years we have worked together, including during this transition,” Beyer said. “I look forward to leading our team in driving further growth and innovation across our businesses and continuing to deliver state-of-the-art products to our customers, allowing them to drive better outcomes for their patients.” Beyer holds a bachelor’s degree in economics from Kalamazoo College and an MBA from Western Michigan University. He also completed the Advanced Management Program at Harvard University. As part of the transition, Lead Independent Director Martha Goldberg Aronson will assume the position of chair of the board on Oct. 31, while Hartman will continue serving as a director through Dec. 31. Hartman will remain with ConMed as an advisor through March 2027. ConMed is based in Largo, Florida, and operates a facility in New Hartford. It manufactures products used in orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.